RBC Capital Maintains Outperform on AdaptHealth, Lowers Price Target to $11
RBC Capital Maintains AdaptHealth(AHCO.US) With Buy Rating, Cuts Target Price to $11
RBC Cuts Price Target on AdaptHealth to $11 From $13, Keeps Outperform Rating
AdaptHealth Analyst Ratings
Truist Financial Maintains AdaptHealth(AHCO.US) With Buy Rating, Announces Target Price $12
AdaptHealth Is Maintained at Buy by Canaccord Genuity
UBS Maintains AdaptHealth(AHCO.US) With Buy Rating, Cuts Target Price to $12
CCORF Maintains AdaptHealth(AHCO.US) With Buy Rating, Cuts Target Price to $13
Baird Maintains AdaptHealth(AHCO.US) With Buy Rating, Cuts Target Price to $14
Truist Financial Maintains AdaptHealth(AHCO.US) With Buy Rating
AdaptHealth Analyst Ratings
Baird Maintains Outperform on AdaptHealth, Lowers Price Target to $14
Analysts Are Bullish on These Healthcare Stocks: Exact Sciences (EXAS), AdaptHealth (AHCO)
Truist Financial Maintains AdaptHealth(AHCO.US) With Buy Rating, Maintains Target Price $13
Baird Maintains AdaptHealth(AHCO.US) With Buy Rating, Maintains Target Price $16
Analysts' Opinions Are Mixed on These Healthcare Stocks: Ardent Health Partners, Inc. (ARDT), AdaptHealth (AHCO) and Ramsay Health Care (OtherRMSYF)
AdaptHealth (AHCO) Gets a Hold From Jefferies
Truist Financial Maintains AdaptHealth(AHCO.US) With Buy Rating, Announces Target Price $13
AdaptHealth Analyst Ratings
RBC Capital Reiterates Outperform on AdaptHealth, Maintains $13 Price Target